Generic drugs will fuel revenue, Biovail chief says

Article Abstract:

According to its chairman, Eugene Melnyk, Biovail Corp. expects the sale of generic drugs to boost its revenue over the next couple of years.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Biovail building war chest

Article Abstract:

Biovail Corp. is issuing new common shares in one of the largest stock issues in Canada in the 2001 year. The company is issuing US$587.5 million in 12.5 million common shares.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Bristol-Myers restates results as it erases $2.5-billion in sales

Article Abstract:

Bristol-Myers Squibb Co. restated its earnings for the 1999, 2000, and 2001 years due to questionable accounting practices. The restatement eliminated US$900 million in profit and $2.5 billion in revenues during those periods.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: